1. Home

Watchdog accuses Pfizer of 'excessive' epilepsy drug price

 
• By James Waldron

The Competition and Markets Authority is investigating why the price of phenytoin sodium capsules to the NHS has risen by more than 25 times since 2012

CMA-screenshot.jpg
The CMA will consider any representations from Pfizer and Flynn Pharma before deciding if the law has been infringed

Latest from News

More from Business